Amed Co., Ltd. (7575.TWO)

Amed Co., Ltd. (7575.TWO) — VMCI valuation read

7575.TWO screens at VMCI 50/100, a 1-point gap below the Healthcare sector median (50). For a mid-cap Amed Co., Ltd. share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

7575.TWO has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: 7575.TWO trades at 16.0x earnings, 11% below the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 16.0% sits 6.0pp above the Healthcare median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 1.5x leaves covenant headroom, which sets the rate-cycle exposure for Amed Co., Ltd..

7575.TWO rose 0.9% over the trailing 7 days, with a +6.4% read on a 30-day basis.